| Market Capitalization (Millions $) |
1,849 |
| Shares
Outstanding (Millions) |
76 |
| Employees |
3,946 |
| Revenues (TTM) (Millions $) |
1,565 |
| Net Income (TTM) (Millions $) |
-7 |
| Cash Flow (TTM) (Millions $) |
-59 |
| Capital Exp. (TTM) (Millions $) |
99 |
Integra Lifesciences Holdings Corp
Integra Lifesciences Holdings Corp is a leading global medical technology company that produces a wide range of innovative and advanced surgical products and devices. The company provides products and solutions for orthopedic and tissue regeneration surgeries, neurosurgery, reconstructive and general surgery, and wound care. Founded in 1989, Integra Lifesciences is headquartered in Plainsboro, New Jersey, and operates in more than 100 countries worldwide.
Products and Services:
The company produces a broad range of surgical products and devices, including:
1. Orthopedic Products: These products are used to treat and repair musculoskeletal injuries, including fractures, soft tissue injuries, and degenerative conditions. Integra Lifesciences offers a range of bone graft substitutes, fixation systems, and instruments for orthopedic surgeons.
2. Tissue Regeneration Products: These products are used to repair and regenerate tissues including skin, bone, and nerves. Integra Lifesciences offers advanced solutions for tissue engineering, wound care, and regenerative medicine.
3. Neurosurgical Products: These products are used in neurosurgery to treat conditions such as brain tumors, skull base surgery, and spinal surgery. Integra Lifesciences provides a diverse range of neurosurgical devices, including cranial fixation systems, neurosurgical instruments, and neuro-monitoring products.
4. Reconstructive and General Surgery Products: These products are used in procedures to restore function and aesthetic appearance after traumatic injuries, cancers or other diseases. Integra Lifesciences provides devices and products for reconstructive surgery of the breast, face, and abdomen.
Operating Segments:
Integra Lifesciences operates through three main segments:
1. Codman Specialty Surgical: This segment is focused on neurosurgery and provides devices and instruments for cranial, spinal, and peripheral nerve surgical procedures.
2. Orthopedics and Tissue Technologies: This segment provides products and devices for orthopedics, wound care, and tissue regeneration.
3. Private Label: This segment provides a range of surgical instruments, such as ear, nose, and throat (ENT) instruments, and surgical implants and equipment to medical device companies.
Acquisitions:
Over the years, Integra Lifesciences has made several strategic acquisitions to enhance its product portfolio and expand its market reach. In 2017, the company acquired Codman Neurosurgery from Johnson & Johnson for $1.05 billion, which includes a portfolio of surgical instruments and devices for neurosurgery.
In 2014, Integra Lifesciences acquired the Derma Sciences wound care business to expand its portfolio of wound care solutions. In 2012, the company bought Ascension Orthopedics, a manufacturer of implants for upper extremity surgical procedures.
Conclusion:
Integra Lifesciences is a leading global medical technology company that offers a wide range of innovative and advanced surgical products and devices. The company's products help surgeons and healthcare professionals to improve patient outcomes and quality of life. With a strong focus on research and development, manufacturing expertise, and global distribution network, Integra Lifesciences is well-positioned to continue providing innovative solutions for the medical industry.
Company Address: 1100 Campus Road Princeton 8540 NJ
Company Phone Number: 275-0500 Stock Exchange / Ticker: NASDAQ IART
|
3.31% 
71.1 %